202811-41-4

Basic information

• Product Name: N-(2-(2-benzyloxyphenyl)ethyl)-N-methylamine
• Synonyms: N-(2-(2-benzyloxyphenyl)ethyl)-N-methylamine
• CAS NO: 202811-41-4
• Molecular Weight: 241.333
• Mol File: 202811-41-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N-(2-(2-benzyloxyphenyl)ethyl)-N-methylamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-(2-benzyloxyphenyl)ethyl)-N-methylamine(202811-41-4)
• EPA Substance Registry System: N-(2-(2-benzyloxyphenyl)ethyl)-N-methylamine(202811-41-4)

Safety Data

• Hazardous Substances Data: 202811-41-4(Hazardous Substances Data)

Upstream product

• 22047-88-7 2-hydroxyphenylacetic acid benzyl ether 
• 202811-40-3 2-(2-benzyloxyphenyl)-N-methylacetamide 

Downstream Products

• 202811-48-1 ((3E)-4-N-((1R)-1-(N-(2-(2-(3-hydroxypropoxy)phenyl)ethyl)-N-methylcarbamoyl)-2-(2-naphthyl)ethyl)-N-methylcarbamoyl-1,1-dimethylbut-3-enyl)carbamic acid tert-butyl ester 
• 202811-46-9 N-[(1R)-1-(N-(2-[2-(3-hydroxypropoxy)phenyl]ethyl)-N-methylcarbamoyl)-2-(2-naphthyl)ethyl]-N-methylcarbamic acid tert-butyl ester 
• 202811-47-0 (2R)-N-(2-(2-(3-hydroxypropoxy)phenyl)ethyl)-N-methyl-2-(methylamino)-3-(2-naphthyl)propionamide 
• 202811-44-7 N-{2-[2-(3-hydroxypropoxy)phenyl]ethyl}-N-methylcarbamic acid tert-butyl ester 
• 202811-43-6 N-(2-(2-hydroxyphenyl)-ethyl)-N-methylcarbamic acid tert-butyl ester 
• 202811-45-8 3-[2-(2-methylamino-ethyl)phenoxy]propan-1-ol 
• 202811-42-5 N-(2-(2-benzyloxyphenyl)-ethyl)-N-methylcarbamic acid tert-butyl ester 

Relevant articles and documents

Compounds with growth hormone releasing properties

There are disclosed novel synthetic peptides of the general formula (I) Compounds of formula (I) stimulate the release of growth hormone from the pituitary in humans and animals. A method for increasing the rate and extent of growth of animals to increase their milk and wool production or for the treatment of ailments, and the use of the compounds of formula (I) for the preparation of medicaments, are also disclosed.

Compounds with growth hormone releasing properties

Novel peptide derivatives, compositions containing them, and their use for treating medical disorders resulting from a deficiency in growth hormone are disclosed. The peptides have the formula (I): STR1 wherein a, b, A, R1, L1, D, R3, R4, R2, L2, E and G are as defined in the specification. These peptides exhibit improved resistance to proteolytic degradation, and hence, improved bioavailability.